Your browser doesn't support javascript.
loading
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression.
Rivalta, B; Attardi, E; Cifaldi, C; Rosti, V; Pacillo, L; Hajrullaj, H; Di Cesare, S; Amodio, D; Algeri, M; Luciani, M; Barzaghi, F; Finocchi, A; Di Matteo, G; Aiuti, A; Locatelli, F; Voso, M T; Palumbo, G; Cancrini, C.
Afiliação
  • Rivalta B; Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Scientific Institute for Research and Healthcare (IRCCS), Rome, Italy.
  • Attardi E; PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Cifaldi C; PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Rosti V; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Pacillo L; Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Scientific Institute for Research and Healthcare (IRCCS), Rome, Italy.
  • Hajrullaj H; Center for the Study of Myelofibrosis, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
  • Di Cesare S; Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Scientific Institute for Research and Healthcare (IRCCS), Rome, Italy.
  • Amodio D; PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Algeri M; PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Luciani M; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Barzaghi F; Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Scientific Institute for Research and Healthcare (IRCCS), Rome, Italy.
  • Finocchi A; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Di Matteo G; Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Scientific Institute for Research and Healthcare (IRCCS), Rome, Italy.
  • Aiuti A; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Locatelli F; Department of Pediatric Hemato-Oncology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, Scientific Institute for Research and Healthcare (IRCCS), Rome, Italy.
  • Voso MT; Department of Pediatric Hemato-Oncology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, Scientific Institute for Research and Healthcare (IRCCS), Rome, Italy.
  • Palumbo G; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cancrini C; Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Scientific Institute for Research and Healthcare (IRCCS), Rome, Italy.
Br J Haematol ; 204(1): e6-e10, 2024 01.
Article em En | MEDLINE | ID: mdl-37921255
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças da Imunodeficiência Primária / Transtornos Linfoproliferativos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças da Imunodeficiência Primária / Transtornos Linfoproliferativos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article